From luscious hair to perfectly-defined brows, here’s your appointment and treatment checklist to get aisle-ready because ...
When it was '21, it was a very weird year - and it seems the same can be said for '22, maybe more so. Yet here we all are, ...
NICE has rejected the use of AstraZeneca and Daiichi Sankyo’s Enhertu as an NHS treatment for advanced HER2-low breast cancer, a decision that the companies have described as “devastating”. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback